Halberd Corp.

0.0019+0.00 (+0%)

Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · HALB · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

1.21M

P/E (TTM)

Basic EPS (TTM)

0.00

Dividend Yield

Recent Filings

8-K

9/19/22Sep 19, 2022

10-Q

8/29/22Aug 29, 2022

8-K

7/2/09Jul 2, 2009

8-K

6/30/09Jun 30, 2009

8-K

6/29/09Jun 29, 2009

About

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

CEO

Mr. William A. Hartman

IPO

9/25/2012

Website

https://halberdcorporation.com

Sector

Healthcare

Industry

Biotechnology